The global radioligand therapy market was valued at
Global Radioligand Therapy Market to Reach $16,658. 4 Million by 2031. ...
Source: globenewswire.com
📰 Technologies Munich News
Page 7 - Technologies Munich News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technologies Munich. Real-time updates on events, politics, business and more.
ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer
ITM to supply Advanced Accelerator Applications on an industrial scale with its high-quality n.c.a. lutetium-177 as core component of the newly approved radiotherapeutic, Pluvicto
Steffen Schuster Lu Endolucinbeta Drug Administration Technologies Munich Advanced Accelerator Applications Chief Executive Officer
Source: itnonline.com
ITM Isotope Technologies Munich SE: ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer
ITM to supply Advanced Accelerator Applications on an industrial scale with its high-quality n.c.a. lutetium-177 as core component of the newly approved radiotherapeutic, PluvictoTM ITM Isotope
Valeria Fisher Kostenloser Wertpapierhandel Ben Orzelek Steffen Schuster Julia Hofmann Susanne Karlsson Lu Endolucinbeta
Source: finanznachrichten.de
Novartis' Pluvicto prostate cancer therapy approved by FDA
Novartis has received a boost to its cancer therapeutics after FDA approved Pluvicto™ and diagnostic Locametz® for advanced prostate cancer.
Lu Endolucinbeta Novarti Pluvicto Oliver Sartor Drug Administration Tulane Cancer Center Medical Director
Source: europeanpharmaceuticalreview.com
ANSTO extends partnership with ITM
The Australian Nuclear Science and Technology Organisation has secured a long-term IP and technology license agreement with a German-based company.
New Zealand Naomi Neilson Ben Miller Australian Nuclear Science Technology Organisation Technologies Munich
Source: lawyersweekly.com.au
ICIF backs ITM | PE Hub
ITM Isotope Technologies Munich, a German radiopharmaceutical biotechnology company, has secured a €33 million ($36 million) investment.
Source: pehub.com
ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals
ICIF and Portland Holdings add to recently secured EUR 25 million equity investment from Grand Pharma, bringing the total in this financing round to EUR 58 million ITM Isotope Technologies Munich
Ben Orzelek Keith Matthews Valeria Fisher Kostenloser Wertpapierhandel Michael Lee Chin Steffen Schuster
Source: finanznachrichten.de
Bruce Power and Kinectrics announce new isotope centre
Bruce Power’s new isotope innovation hub and the recently unveiled Kinectrics centre for medical isotopes and nuclear energy are set to strengthen Ontario’s…
Source: thepost.on.ca
Bruce Power and Kinectrics announce new isotope centre
Bruce Power’s new isotope innovation hub and the recently unveiled Kinectrics centre for medical isotopes and nuclear energy are set to strengthen Ontario’s…
Source: thepost.on.ca
Bruce Power and Kinectrics announce new isotope centre
Bruce Power’s new isotope innovation hub and the recently unveiled Kinectrics centre for medical isotopes and nuclear energy are set to strengthen Ontario’s…
Source: lakeshoreadvance.com